Here’s how to improve it
Better calibration could make diagnosis more efficient and less costly
Researchers share findings on projects covering patient support, costs, and operations management
Life science and tech companies bump heads to interpret the new map
Huge amounts of biometric, DNA, and diagnostic data enable personalized medicine. They also enable unscrupulous and discriminatory marketing.
A primer for life science manufacturers
A timeline of FDA and Sparta System activities
Easing regulatory compliance
A concise history of FDA’s risk-based Site Selection Model
An interview with Sparta System’s Stephen McCarthy
What can we learn from the organizational cultures of different industries?
Instead of being a commodity, a healthy work culture should be built directly into the corporate DNA
ISO vs. FDA audits, Baldrige winners, and what we can learn from GE
How BioBridge Global leverages a digital QMS in the heavily regulated world of regenerative medicines
From digital submissions to integrated document control, the agency moves into the lean arena
By scaring off small medical-device companies, Canada could limit number of important and innovative products
For answers to some troubling life-science questions, ask a quality professional
Finch Therapeutics forges a QMS for a life-saving treatment not yet approved by the FDA
Compliance, quality, and serving the patient
Welcome home!